Stock & Company Details
AstraZeneca PLC $AZN
Price:
N/A
N/A
N/A
$255B
52 Week High:
N/A
10 Day Average Volume:
N/A
24.32
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
AZN technical indicators
Latest AstraZeneca PLC (AZN) indicator readings as of 2026-08-28.
AZN's 14-day RSI is 45.4, in neutral territory. At $162.70 it is trading 2.3% above its 200-day moving average of $159.03, and below its 50-day average of $170.85. Price sits in the middle of its Bollinger Bands ($153.91 to $169.36). ADX reads 17.5, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Finance Bot
Ask your questions
Start by typing a question below.
